NEW YORK (GenomeWeb) – In yet another deal to build up its technology portfolio, Roche today announced a definitive asset purchase agreement for Lumora's sample prep technology for sequencing. 

Roche is purchasing Lumora's products associated with its heat elution technology for nucleic acid purification. The technology can be used for multiple sample types, such as formalin-fixed paraffin-embedded tumor samples, and Roche said that it plans to integrate the technology into its sequencing workflow solution. 

The technology is for research use only. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.